Segall Bryant & Hamill’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-152,014
| Closed | -$1.23M | – | 723 |
|
|
2022
Q2 | $1.23M | Buy |
152,014
+44,973
| +42% | +$364K | 0.01% | 476 |
|
|
2022
Q1 | $1.49M | Buy |
107,041
+267
| +0.3% | +$3.7K | 0.01% | 475 |
|
|
2021
Q4 | $3M | Buy |
106,774
+4,970
| +5% | +$139K | 0.03% | 379 |
|
|
2021
Q3 | $3.46M | Buy |
101,804
+2,708
| +3% | +$92K | 0.03% | 395 |
|
|
2021
Q2 | $4.05M | Buy |
99,096
+6,002
| +6% | +$245K | 0.04% | 364 |
|
|
2021
Q1 | $3.75M | Sell |
93,094
-1,586
| -2% | -$63.9K | 0.04% | 387 |
|
|
2020
Q4 | $5.6M | Sell |
94,680
-1,782
| -2% | -$105K | 0.06% | 275 |
|
|
2020
Q3 | $4.69M | Buy |
96,462
+70,037
| +265% | +$3.41M | 0.06% | 269 |
|
|
2020
Q2 | $1.28M | Buy |
26,425
+12,475
| +89% | +$603K | 0.02% | 396 |
|
|
2020
Q1 | $388K | Buy |
+13,950
| New | +$388K | 0.01% | 630 |
|